1138 related articles for article (PubMed ID: 32355963)
1. Microglial exosomes facilitate α-synuclein transmission in Parkinson's disease.
Guo M; Wang J; Zhao Y; Feng Y; Han S; Dong Q; Cui M; Tieu K
Brain; 2020 May; 143(5):1476-1497. PubMed ID: 32355963
[TBL] [Abstract][Full Text] [Related]
2. Reactive microglia enhance the transmission of exosomal α-synuclein via toll-like receptor 2.
Xia Y; Zhang G; Kou L; Yin S; Han C; Hu J; Wan F; Sun Y; Wu J; Li Y; Huang J; Xiong N; Zhang Z; Wang T
Brain; 2021 Aug; 144(7):2024-2037. PubMed ID: 33792662
[TBL] [Abstract][Full Text] [Related]
3. Plasma exosomes impair microglial degradation of α-synuclein through V-ATPase subunit V1G1.
Li Y; Wang Y; Kou L; Yin S; Chi X; Sun Y; Wu J; Jin Z; Zhou Q; Zou W; Wang T; Xia Y
CNS Neurosci Ther; 2024 May; 30(5):e14738. PubMed ID: 38702933
[TBL] [Abstract][Full Text] [Related]
4. Microglia as modulators of exosomal alpha-synuclein transmission.
Xia Y; Zhang G; Han C; Ma K; Guo X; Wan F; Kou L; Yin S; Liu L; Huang J; Xiong N; Wang T
Cell Death Dis; 2019 Feb; 10(3):174. PubMed ID: 30787269
[TBL] [Abstract][Full Text] [Related]
5. Preferential microglial activation associated with pathological alpha synuclein transmission.
Kim YE; Lai TT; Kim YJ; Jeon B
J Clin Neurosci; 2020 Nov; 81():469-476. PubMed ID: 33222964
[TBL] [Abstract][Full Text] [Related]
6. TNFRSF10B is involved in motor dysfunction in Parkinson's disease by regulating exosomal α-synuclein secretion from microglia.
Dai M; Yan L; Yu H; Chen C; Xie Y
J Chem Neuroanat; 2023 Apr; 129():102249. PubMed ID: 36791922
[TBL] [Abstract][Full Text] [Related]
7. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?
Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR
Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049
[TBL] [Abstract][Full Text] [Related]
8. Exosomes of BV-2 cells induced by alpha-synuclein: important mediator of neurodegeneration in PD.
Chang C; Lang H; Geng N; Wang J; Li N; Wang X
Neurosci Lett; 2013 Aug; 548():190-5. PubMed ID: 23792198
[TBL] [Abstract][Full Text] [Related]
9. Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson's disease.
George S; Rey NL; Tyson T; Esquibel C; Meyerdirk L; Schulz E; Pierce S; Burmeister AR; Madaj Z; Steiner JA; Escobar Galvis ML; Brundin L; Brundin P
Mol Neurodegener; 2019 Aug; 14(1):34. PubMed ID: 31419995
[TBL] [Abstract][Full Text] [Related]
10. Ciita Regulates Local and Systemic Immune Responses in a Combined rAAV-α-synuclein and Preformed Fibril-Induced Rat Model for Parkinson's Disease.
Fredlund F; Jimenez-Ferrer I; Grabert K; Belfiori LF; Luk K; Swanberg M
J Parkinsons Dis; 2024; 14(4):693-711. PubMed ID: 38728204
[TBL] [Abstract][Full Text] [Related]
11. Exosomes from patients with Parkinson's disease are pathological in mice.
Han C; Xiong N; Guo X; Huang J; Ma K; Liu L; Xia Y; Shen Y; Li J; Jiang H; Wang L; Guo S; Xu X; Zhang G; Liu J; Cao X; Zhang Z; Lin Z; Wang T
J Mol Med (Berl); 2019 Sep; 97(9):1329-1344. PubMed ID: 31302715
[TBL] [Abstract][Full Text] [Related]
12. Activated microglia facilitate the transmission of α-synuclein in Parkinson's disease.
Zheng T; Zhang Z
Neurochem Int; 2021 Sep; 148():105094. PubMed ID: 34097990
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal dysfunction increases exosome-mediated alpha-synuclein release and transmission.
Alvarez-Erviti L; Seow Y; Schapira AH; Gardiner C; Sargent IL; Wood MJ; Cooper JM
Neurobiol Dis; 2011 Jun; 42(3):360-7. PubMed ID: 21303699
[TBL] [Abstract][Full Text] [Related]
14. Regionally-specific microglial activation in young mice over-expressing human wildtype alpha-synuclein.
Watson MB; Richter F; Lee SK; Gabby L; Wu J; Masliah E; Effros RB; Chesselet MF
Exp Neurol; 2012 Oct; 237(2):318-34. PubMed ID: 22750327
[TBL] [Abstract][Full Text] [Related]
15. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
[TBL] [Abstract][Full Text] [Related]
16. The relation between α-synuclein and microglia in Parkinson's disease: Recent developments.
Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
Neuroscience; 2015 Aug; 302():47-58. PubMed ID: 25684748
[TBL] [Abstract][Full Text] [Related]
17. α-Synuclein-carrying extracellular vesicles in Parkinson's disease: deadly transmitters.
Chistiakov DA; Chistiakov AA
Acta Neurol Belg; 2017 Mar; 117(1):43-51. PubMed ID: 27473175
[TBL] [Abstract][Full Text] [Related]
18. Temporal evolution of microglia and α-synuclein accumulation following foetal grafting in Parkinson's disease.
Olanow CW; Savolainen M; Chu Y; Halliday GM; Kordower JH
Brain; 2019 Jun; 142(6):1690-1700. PubMed ID: 31056668
[TBL] [Abstract][Full Text] [Related]
19. p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease.
Chen J; Mao K; Yu H; Wen Y; She H; Zhang H; Liu L; Li M; Li W; Zou F
J Neuroinflammation; 2021 Dec; 18(1):295. PubMed ID: 34930303
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cδ upregulation in microglia drives neuroinflammatory responses and dopaminergic neurodegeneration in experimental models of Parkinson's disease.
Gordon R; Singh N; Lawana V; Ghosh A; Harischandra DS; Jin H; Hogan C; Sarkar S; Rokad D; Panicker N; Anantharam V; Kanthasamy AG; Kanthasamy A
Neurobiol Dis; 2016 Sep; 93():96-114. PubMed ID: 27151770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
